These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37705417)

  • 1. Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs.
    Pritchard C; Al-Nadaf S; Rebhun RB; Willcox JL; Skorupski KA; Lejeune A
    Vet Comp Oncol; 2023 Dec; 21(4):717-725. PubMed ID: 37705417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Gillem J; Giuffrida M; Krick E
    Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
    Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma.
    Wiley JL; Rook KA; Clifford CA; Gregor TP; Sorenmo KU
    Vet Comp Oncol; 2010 Sep; 8(3):221-33. PubMed ID: 20691029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
    Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
    Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
    Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
    Alexander CK; Cronin KL; Silver M; Gardner HL; London C
    J Small Anim Pract; 2019 Jan; 60(1):32-37. PubMed ID: 30209807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
    Woodruff MJ; Heading KL; Bennett P
    Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
    Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011-2016) and comparison with doxorubicin-based chemotherapy.
    Faulhaber EA; Janik E; Thamm DH
    J Vet Intern Med; 2021 Jul; 35(4):1929-1934. PubMed ID: 34227148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation.
    Lane A; Black M; Wyatt K
    Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).
    Rassnick KM; Ruslander DM; Cotter SM; Al-Sarraf R; Bruyette DS; Gamblin RM; Meleo KA; Moore AS
    J Am Vet Med Assoc; 2001 May; 218(9):1444-8. PubMed ID: 11345308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
    Sorenmo KU; Jeglum KA; Helfand SC
    J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
    J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HYPOFRACTIONATED RADIOTHERAPY FOR MACROSCOPIC CANINE SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY OF 50 CASES TREATED WITH A 5 × 6 GY PROTOCOL WITH OR WITHOUT METRONOMIC CHEMOTHERAPY.
    Cancedda S; Marconato L; Meier V; Laganga P; Roos M; Leone VF; Rossi F; Bley CR
    Vet Radiol Ultrasound; 2016 Jan; 57(1):75-83. PubMed ID: 26551348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
    Burton JH; Powers BE; Biller BJ
    Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma.
    Finotello R; Henriques J; Sabattini S; Stefanello D; Felisberto R; Pizzoni S; Ferrari R; Marconato L
    Vet Comp Oncol; 2017 Jun; 15(2):493-503. PubMed ID: 26792231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
    Cannon C; Borgatti A; Henson M; Husbands B
    J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined palliative hypofractionated radiation and carboplatin chemotherapy of intranasal tumours in dogs].
    Schwietzer A; Kessler M; Kandel-Tschiederer B
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Oct; 40(5):333-40. PubMed ID: 23076017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.